Duration of Payments. The amounts payable under Section 4.3 shall be paid on a Licensed Product-by-Licensed Product and country-by-country basis until the Royalty Expiration Date applicable to each Licensed Product in each country.
Appears in 1 contract
Duration of Payments. The amounts payable under Section 4.3 6.4(a) shall be paid on a Licensed Product-by-Licensed Product and country-by-country basis until the expiration of the Royalty Expiration Date Term applicable to each Licensed Product in each country.
Appears in 1 contract
Sources: Research & License Agreement (Achillion Pharmaceuticals Inc)
Duration of Payments. The amounts payable under Section 4.3 and Section 4.6 shall be paid on a Licensed Product-by-Licensed Product and country-by-country basis until the Royalty Expiration Date applicable to each Licensed Product in each country.
Appears in 1 contract
Sources: Sublicense Agreement (Navidea Biopharmaceuticals, Inc.)
Duration of Payments. The amounts payable under Section 4.3 and Section 4.4 shall be paid on a Licensed Product-by-Licensed Product and country-by-country basis until the expiration of the Royalty Expiration Date Term applicable to each Licensed Product in each country.
Appears in 1 contract